一、论文
1.Liu Y.,Zhan Y.,Chen Z.,He A.,Li J.,Wu H.,Liu L.,Zhuang C.,Lin J.,Guo X.,Zhang Q.,Huang W.*,Cai Z*..Directing cellular information flow via CRISPR signal conductors.NATURE METHODS.2016, 13 (11) :938-944.
2.Li Z, Xu H, Yu L, Wang J, Meng Q, Mei H, Cai Z, Chen W, Huang W. Patient-derived renal cell carcinoma organoids for personalized cancer therapy.[J]. Clinical and translational medicine,2022,12(7).
3.Li Z, Xu H, Gong Y, Chen W, Zhan Y, Yu L, Sun Y, Li A, He S, Guan B, Wu Y, Xiong G, Fang D, He Y, Tang Q, Yao L, Hu Z, Mei H, He Z, Cai Z, Guo Y, Li X, Zhou L, Huang W. Patient-Derived Upper Tract Urothelial Carcinoma Organoids as a Platform for Drug Screening. Advanced Science. 2021 Dec 16:e2103999.
4. Ma Y.#,Mao G.#,Huang W.#,Wu G.,Yin W.,Ji X.,Deng Z.,Cai Z.,Zhang X.,He Z.*,Cui Z.*.Quantum Dot Nanobeacons for Single RNA Labeling and Imaging.Journal of the American Chemical Society.2019.141(34):13454-13458.
5.Zhan H.#,Zhou Q#,Gao Q.#,Li J.#,Huang W.*,Liu Y.*.Multiplexed promoterless gene expression with CRISPReader.Genome Biology.2019,20:113.
6.Wang Z.#,Li K.#,Chen W.#,Wang X.,Huang Y.,Wang W.,Wu W.,Cai Z.*,Huang W.*.Modulation of SRSF2 expression reverses the exhaustion of TILs via the epigenetic regulation of immune checkpoint molecules.Cellular and molecular life sciences .2020;77(17):3441–3452.
7.Ma Y, Mao G, Wu G, Cui Z, Zhang XE, Huang W. .CRISPR-dCas9-Guided and Telomerase-Responsive Nanosystem for Precise Anti-Cancer Drug Delivery.ACS APPLIED MATERIALS & INTERFACES.2021;13(7):7890-7896.
8.Wang J, Feng X, Li Z, Chen Y, Huang W*. .Patient-derived organoids as a model for tumor research.Progress in Molecular Biology and Translational Science.22;189(1):259-326.
9.Fan J.#*,Liu Y.#,Liu Lisa,Huang Y., Li X.,Huang W.*.A Multifunction Lipid-Based CRISPR-Cas13a Genetic Circuit Delivery System for Bladder Cancer Gene Therapy.ACS Synthetic Biology.2020,9(2):343-355.
10.Ma Y.#*, Mao G.#,Wu G.#,Fan J.,He Z.,Huang W.*.A novel nano-beacon based on DNA functionalized QDs for intracellular telomerase activity monitoring.SENSORS AND ACTUATORS B-CHEMICAL.2020,304:127385.
11.Xie H.#,Zhan H.#,Gao Q.#,Li J.#,Zhou Q,Chen Z.,Liu Y.,Ding M.,Xiao H.,Liu Y.*,Huang W.*,Cai Z.*.Synthetic artificial "long non-coding RNAs" targeting oncogenic microRNAs and transcriptional factors inhibit malignant phenotypes of bladder cancer cells.CANCER LETTERS.2018,9(3):209;94-106.
二、专利授权
1.黄卫人 刘宇辰 詹永豪 蔡志明，四环素诱导型人工 micro RNA 元件，ZL 2015 1 0690643.8，授权日：2021-7-1，发明专利
2.黄卫人 陈志聪 刘宇辰 蔡志明，一种茶碱诱导性RNA干扰开关系统及其基因调节方法和用途，ZL 2016 1 0741107.0，授权日：2020-02-21，发明专利
3.黄卫人 蔡志明 林帆，一种高效调控肿瘤细胞表型的光控基因装置，ZL 2016 1 0795393.9，授权日：2019-12-17，发明专利
4.黄卫人 刘宇辰 蔡志明，特异探测膀胱癌细胞的分子遗传装置，ZL 2016 1 0892544.2，授权日：2019-09-17，发明专利
5.黄卫人 刘宇辰 蔡志明 许文 陈志聪，针对MALAT-1基因的asRNA及其应用，ZL 2016 1 0321374.2，授权日：2019-5-13，发明专利
6.黄卫人 刘宇辰 蔡志明 陈志聪，一种基于CRISPR-Cas9的基因调控装置及基因调控方法，ZL 2016 1 0741981.4，授权日：2019-09-13，发明专利
7.黄卫人 刘宇辰 蔡志明，人 NF-kB的核酸适配体及其应用，ZL 2014 1 0208520.1，授权日：2018-06-05，发明专利
8.黄卫人 刘宇辰 蔡志明，特异探测膀胱癌细胞的分子遗传装置的构建方法，ZL 2014 1 0441470.1，授权日：2017-01-04，发明专利
9.马英新 黄卫人，端粒酶活性检测试剂盒及检测方法，ZL 2018 1 0503919.0，授权日：2021-06-15，发明专利
10. 刘宇辰 黄卫人 蔡志明，人β-catenin的核酸适配体及其应用，ZL 2014 1 0841057.4，授权日：2018-03-02，发明专利
